ClinicalTrials.gov
public full text
Public Domain
Remicade Safety Line (Study P03236)(COMPLETED)
The goal of this study is to implement instruments that would increase the treating physician's awareness of the necessary tuberculosis screening when starting a new patient on infliximab (Remicade) therapy who has not reacted sufficiently to disease-modifying preparations, including methotrexate.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Point-of-care Triage Test for Active Tuberculosis#217202
- Virtual screening e dinâmica molecular para identificação de inibidores da enzima corismato sintase de Mycobacterium tuberculosis#946160
- Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis#181825
- Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis: A cross-country validation study#1015763
- Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis#829730
Record · ID 1138757
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive